MARKET

TMDX

TMDX

Transmedics Group
NASDAQ
93.20
-2.61
-2.72%
After Hours: 106.74 +13.54 +14.53% 19:59 05/08 EDT
OPEN
96.94
PREV CLOSE
95.81
HIGH
98.55
LOW
92.49
VOLUME
2.22M
TURNOVER
--
52 WEEK HIGH
177.37
52 WEEK LOW
55.00
MARKET CAP
3.15B
P/E (TTM)
92.55
1D
5D
1M
3M
1Y
5Y
1D
TRANSMEDICS GROUP INC <TMDX.O>: JP MORGAN RAISES TARGET PRICE TO $114 FROM $81
Reuters · 4h ago
Transmedics raises 2025 revenue guidance to $565M-$585M with 28%-32% growth driven by OCS adoption
Seeking Alpha · 5h ago
Compared to Estimates, TransMedics (TMDX) Q1 Earnings: A Look at Key Metrics
NASDAQ · 8h ago
TransMedics Group: Strong Financial Performance and Promising Growth Prospects Drive Buy Rating
TipRanks · 9h ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 10h ago
TransMedics raises 2025 revenue outlook to $565M-$585M from $530M-$552M
TipRanks · 11h ago
BRIEF-Transmedics Group Q1 Gross Profit USD 88.228 Million
Reuters · 11h ago
*TransMedics Group 1Q Rev $143.5M >TMDX
Dow Jones · 11h ago
More
About TMDX
More
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Recently
Symbol
Price
%Change

Webull offers TransMedics Group Inc stock information, including NASDAQ: TMDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TMDX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TMDX stock methods without spending real money on the virtual paper trading platform.